Chronic early postnatal administration of ethylmalonic acid to rats causes behavioral deficit

Behavioural Brain Research

Volumn 197, Issue 2, 2009, Pages 364-370

  Schuck, Patrícia Fernanda ^a   Ferreira, Gustavo da Costa ^a   Viegas, Carolina Maso ^a   Tonin, Anelise Miotti ^a   Busanello, Estela Natacha Brandt ^a   Pettenuzzo, Leticia Ferreira ^a   Netto, Carlos Alexandre ^a   Wajner, Moacir ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Elevated plus maze; Ethylmalonic acid; Ethylmalonic aciduria; Rat; SCAD deficiency; Water maze

Indexed keywords

CARBOXYLIC ACID; CREATINE KINASE; ETHYLMALONIC ACID; FREE RADICAL; MALONIC ACID DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; BIOENERGY; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; IN VITRO STUDY; LEARNING DISORDER; LIPID PEROXIDATION; LONG TERM EXPOSURE; MALE; MAZE TEST; MEMORY DISORDER; METABOLITE; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WATER LOADING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; CELLS, CULTURED; CREATINE KINASE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INJECTIONS, SUBCUTANEOUS; LIPID PEROXIDATION; MALE; MALONATES; MAZE LEARNING; MEMORY; RATS; RATS, WISTAR; SPECTROPHOTOMETRY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 58149333453     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.09.031     Document Type: Article

References (50)

1. Arteni N.S., Salgueiro J., Torres I., Achaval M., and Netto C.A. Neonatal cerebral hypoxia-ischemia causes lateralized memory impairments in the adult rat. Brain Res 973 (2003) 171-178
2. Barschak A.G., Ferreira G.C., Andre K.R., Schuck P.F., Viegas C.M., Tonin A., et al. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. Metab Brain Dis 21 (2006) 11-19
3. Bennet M.J., Weinberger M.J., Kobory J.A., Rinaldo P., and Burlina A.B. Mitochondrial short-chain l-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 39 (1996) 185-188
4. Bickford P.C., Shukitt-Hale B., and Joseph J. Effects of aging on cerebellar noradrenergic function and motor learning: nutritional interventions. Mech Ageing Dev 111 (1999) 141-154
5. Burlina A., Zacchello F., Dionisi-Vici C., Bertini E., Sabetta G., Bennet M.J., et al. New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 14 (1991) 1522-1523
6. Burlina A.B., Dionisi-Vici C., Bennett M.J., Gibson K.M., Servidei S., Bertini E., et al. A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr 124 (1994) 79-86
7. Da Silva A.L., Piato A.L., Bardini S., Netto C.A., Nunes D.S., and Elisabetsky E. Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice. J Ethnopharmacol 95 (2004) 199-203
8. Da Silva V.A., Malheiros L.R., and Bueno F.M.R. Effect of toluene exposure during gestation on neurobehavioral development of rats and hamsters. Braz J Med Biol Res 23 (1990) 533-537
9. Davis P.H., and Squire L.R. Protein synthesis and memory: a review. Psychol Bull 96 (1984) 518-559
10. Dawson D.B., Waber L., Hale D.E., and Bennet M.J. Transient organic aciduria and persistent lactic acidemia in a patient with short-chain acyl-Coenzyme A dehydrogenase deficiency. J Pediatr 126 (1995) 69-71
11. Devan B.D., Goad E.H., and Petri H.L. Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze. Neurobiol Learn Mem 66 (1996) 305-323
12. Dreyfus H., Ferret B., Harth S., Giorgio A., Durand M., Freysz L., et al. Metabolism and function of gangliosides in developing neurons. J Neurosci Res 12 (1984) 311-322
13. Dutra J.C., Wajner M., Wannmacher C.M., Wannmacher L.E., Pires R.F., and Rosa-Junior A. Effect of postnatal methylmalonate administration on adult rat behavior. Braz J Med Biol Res 24 (1991) 595-605
14. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-421
15. Ferreira G.C., André K.R., Schuck P.F., Viegas C.M., Tonin A., Coelho D.M., et al. Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues. Metab Brain Dis 21 (2006) 29-39
16. Garavaglia B., Colamaria V., Carrara F., Tonin P., Rimoldi M., and Uziel G. Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. J Inherit Metab Dis 17 (1994) 301-303
17. Garcia-Silva M.T., Campos Y., Ribes A., Briones P., Cabello A., Santos Borbujo J., et al. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome oxidase deficiency. J Pediatr 125 (1994) 843-844
18. Garcia-Silva M.T., Ribes A., Campos Y., Garavaglia B., and Arenas J. Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria. Pediatr Neurol 17 (1997) 165-170
19. Goldman-Rakic P.S. The 'psychic' neuron of the cerebral cortex. Ann N Y Acad Sci 868 (1999) 13-26
20. Hughes B.P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7 (1962) 597-603
21. Leipnitz G., Schuck P.F., Ribeiro C.A., Dalcin K.B., Assis D.R., Barschak A.G., et al. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. Neurochem Res 28 (2003) 771-777
22. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
23. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
24. McDonald R.J., and Hong N.S. Rats with hippocampal damage are impaired on place learning in the water task when overtrained under constrained conditions. Hippocampus 10 (2000) 153-161
25. McDonald R.J., King A.L., Foong N., Rizos Z., and Hong N.S. Neurotoxic lesions of the medial prefrontal cortex or medial striatum impair multiple-location place learning in the water task: evidence for neural structures with complementary roles in behavioural flexibility. Exp Brain Res 187 (2008) 419-427
26. Mekhfi H., Veksler V., Mateo P., Maupoil V., Rochette L., and Ventura-Clapier R. Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circ Res 78 (1996) 1016-1027
27. Mello C.F., Somer J.E., Tavaroni V., Graciolli R., Wu V., Torres G., et al. Effects of postnatal methylmalonate administration on neurobehavioral development of rats. Braz J Med Biol Res 27 (1994) 655-661
28. Morris R.G.M., Garrud P., Rawlins J.N.P., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
29. Okuyaz C., Ezgü F.S., Biberoglu G., Zeviani M., Tiranti V., and Yilgör E. Severe infantile hypotonia with ethylmalonic aciduria: case report. J Child Neurol 23 (2008) 703-705
30. Ozand P.T., Rashed M., Millington D.S., Sakati N., Hazzaa S., Rahbeeni Z., et al. Ethylmalonic aciduria: an organic acidemia with CNS involvement and vasculopathy. Brain Dev 16 (1994) 12-22
31. Pedersen C.B., Kølvraa S., Kølvraa A., Stenbroen V., Kjeldsen M., Ensenauer R., et al. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 124 (2008) 43-56
32. Pettenuzzo L.F., Schuck P.F., Fontella F., Wannmacher C.M.D., Wyse A.T., Dutra-Filho C.S., et al. Ascorbic acid prevents cognitive deficits caused by chronic administration of propionic acid to rats in the water maze. Pharmacol Biochem Behav 73 (2002) 623-629
33. Rinaldo P., Matern D., and Bennett M.J. Fatty acid oxidation disorders. Annu Rev Physiol 64 (2002) 477-502
34. Rinaldo P., Raymond K., al-Odaib A., and Bennett M.J. Clinical and biochemical features of fatty acid oxidation disorders. Curr Opin Pediatr 10 (1998) 615-621
35. Roe C.R., and Ding J. Mitochondrial fatty acids disorders. In: Scriver C.R., Beaudet A.L., Sly W.L., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill Co., New York 1909-1963
36. Roisen F.J., Bartfeld H., Nagele R., and Yorke G. Ganglioside stimulation of axonal sprouting in vivo. Science 214 (1981) 577-578
37. Schuck P.F., Leipnitz G., Ribeiro C.A., Dalcin K.B., Assis D.R., Barschak A.G., et al. Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats. Neurochem Res 27 (2002) 1633-1639
38. Serrano F., and Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3 4 (2004) 431-443
39. Smart J.L., and Dobbing J. Vulnerability of developing brain II. Effect of early nutritional deprivation on reflex ontogeny and development of behavior in the rat. Brain Res 28 (1971) 85-95
40. Stachowiak O., Dolder M., Wallimann T., and Richter C. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J Biol Chem 273 (1998) 16694-16699
41. Sutherland R.J., Whishaw I.Q., and Kolb B. A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav Brain Res 7 (1983) 133-153
42. Tein I., Elpeleg O., Ben-Zeev B., Jorman S.H., Lossos A., Lev D., et al. Short-chain acyl-CoA dehydrogenase gene mutation (c.319C > T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin. Mol Genet Metab 93 (2008) 179-189
43. Tein I., Haslam R.H.A., Rhead W.J., Bennet M.J., Becker L.E., and Vockley J. Short-chain acyl-CoA dehydrogenase deficiency: a cause of ophthalmoplegia and multicore myopathy. Neurology 52 (1999) 366-372
44. Tiranti V., D'Adamo P., Briem E., Ferrari G., Mineri R., Lamantea E., et al. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74 (2004) 239-252
45. van Maldegem B.T., Duran M., Wanders R.J., Niezen-Koning K.E., Hogeveen M., Ijlst L., et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. J Am Med Assoc 296 8 (2006) 943-952
46. Vasques V.C., Brinco F., and Wajner M. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks. J Neurol Sci 232 (2005) 11-21
47. Waisbren SE, Levy HL, Noble M, Matern D, Gregersen N, Pasley K, et al. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms. Mol Genet Metab 2008;95:39-45.
48. Warren S.G., and Juraska J.M. Sex differences and estropausal phase effects on water maze performance in aged rats. Neurobiol Learn Mem 74 (2000) 229-240
49. Winick M., and Noble A. Quantitative changes in DNA, RNA and protein during prenatal and postnatal growth in rat. Dev Biol 12 (1965) 451-466
50. Wolosker H., Panizzutti R., and Englender S. Inhibition of creatine kinase by S-nitrosoglutathione. FEBS Lett 392 (1996) 274-276